Only 2 colorectal cancer cell lines with BRAF mutations RKO and HT-29 show MYC amplifications and both are more sensitive to the NUAK inhibitor WZ4003 than the mean sensitivity of the BRAF mutant group of colorectal cancer cell lines. The gene discussed is MYC; the disease is colorectal cancer.